More tools:Markets·Screener·Research·Chat

HealthEquity, Inc (HQY) Financial Statements

HealthEquity, Inc
SIC 7389 · SERVICES-BUSINESS SERVICES, NEC
FIGI BBG001T8JKN8
XNAS · usd
94.15▲ 0.79 (0.85%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close93.36
Day's Range93.09 – 95.54
52-Week Range72.66 – 107.62
Volume872.1K
Avg Volume809.3K
Share Statistics
Shares Outstanding
Employees2,814
ExchangeXNAS
Listed2014-07-31
Share count as of August 20, 2026
Loading Income Statement…
Key questions about HealthEquity, Inc (HQY)
What is HealthEquity, Inc's Market Cap?
HealthEquity, Inc's Market Cap is $7.8B, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's Enterprise Value?
HealthEquity, Inc's Enterprise Value is $8.5B, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's Trailing P/E?
HealthEquity, Inc's Trailing P/E is 32.9×, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's Price / Sales?
HealthEquity, Inc's Price / Sales is 5.7×, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's EV / Revenue?
HealthEquity, Inc's EV / Revenue is 6.2×, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's EV / EBITDA?
HealthEquity, Inc's EV / EBITDA is 16.5×, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's Revenue (TTM)?
HealthEquity, Inc's Revenue (TTM) is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's Net Income (TTM)?
HealthEquity, Inc's Net Income (TTM) is $236.5M, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's EBITDA?
HealthEquity, Inc's EBITDA is $509.0M, based on as-reported figures from SEC (XBRL) filings.
What is HealthEquity, Inc's Diluted EPS (TTM)?
HealthEquity, Inc's Diluted EPS (TTM) is 2.86, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJul 31, 2026Apr 30, 2026Jan 31, 2026Oct 31, 2025Jul 31, 2025Apr 30, 2025Jan 31, 2025Oct 31, 2024Jul 31, 2024Apr 30, 2024Jan 31, 2024Oct 31, 2023Jul 31, 2023Apr 30, 2023Jan 31, 2023Oct 31, 2022
Revenue
Total revenue
YoY growth+7.6%+7.2%+7.3%+7.2%
Cost of revenue
Total cost of revenue
Gross profit
% of revenue73.5%72.3%68.2%70.8%
Operating expenses
Sales and marketing
Technology and development
General and administrative
Amortization of acquired intangible assets
Merger integration
Total operating expenses
% of revenue45.4%43.2%46.9%46.4%
Income from operations
% of revenue28.1%29.0%21.2%24.4%
Other expense
Interest expense
Other income, net
Total other expense
Income before income taxes
Income tax provision
Net income
% of revenue18.7%19.6%14.9%16.0%
Basic (in usd per share)
Diluted (in usd per share)